UPDATE 1-AstraZeneca's Tagrisso to cost $12,750 for a month's supply
November 17, 2015 at 08:08 AM EST
LONDON, Nov 17 (Reuters) - AstraZeneca's new lung cancer pill Tagrisso, which won early U.S. approval on Friday, will cost $12,750 for a month's supply.
